Ioannis Avgerinos Selected Research

Ioannis Avgerinos Research Topics

18	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2018
11	Body Weight (Weight, Body) 05/2024 - 01/2018
7	Heart Failure 12/2023 - 01/2019
6	Stroke (Strokes) 01/2022 - 01/2020
4	Nausea 01/2022 - 01/2018
4	Myocardial Infarction 01/2022 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2019
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023 - 01/2021
3	Vomiting 01/2022 - 01/2018
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 01/2019
2	Chronic Renal Insufficiency 12/2023 - 10/2023
2	Hypoglycemia (Reactive Hypoglycemia) 10/2023 - 01/2020
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022 - 01/2021
1	Obesity 05/2024
1	Weight Loss (Weight Reduction) 04/2024
1	Fatty Liver 12/2023
1	Neoplasms (Cancer) 11/2023
1	Thromboembolism 11/2023
1	Wounds and Injuries (Trauma) 10/2023
1	Overweight 01/2022
1	Infections 01/2021
1	Eye Diseases (Eye Disease) 01/2020
1	Pancreatitis 01/2020
1	Diarrhea 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Exanthema (Rash) 01/2019
1	Retinal Detachment (Retinal Detachments) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019

14	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2019
7	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023 - 01/2018
6	SodiumIBA 10/2023 - 01/2019
5	semaglutideIBA 04/2024 - 01/2018
5	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 01/2019
4	Insulin (Novolin)FDA Link 10/2023 - 01/2021
4	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2021
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 01/2018
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 07/2021 - 01/2019
3	Hypoglycemic Agents (Hypoglycemics)IBA 05/2024 - 01/2022
3	tirzepatideIBA 05/2024 - 01/2022
3	Blood Glucose (Blood Sugar)IBA 10/2023 - 01/2020
3	Liraglutide FDA Link 01/2021 - 01/2020
2	InsulinsIBA 10/2023 - 10/2021
2	Exenatide (Byetta)FDA Link 01/2021 - 01/2021
2	dapagliflozinIBA 01/2021 - 01/2019
2	empagliflozinIBA 01/2021 - 01/2020
2	CanagliflozinIBA 01/2021 - 01/2020
1	Sodium-Glucose Transport ProteinsIBA 12/2023
1	Lenalidomide (CC 5013)FDA Link 11/2023
1	Monoclonal AntibodiesIBA 11/2023
1	Bortezomib (Velcade)FDA Link 11/2023
1	daratumumabIBA 11/2023
1	carfilzomibIBA 11/2023
1	Short-Acting InsulinIBA 10/2023
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2022
1	Insulin Lispro (Humalog)FDA Link 10/2021
1	omega-Chloroacetophenone (Mace)IBA 04/2021
1	pramlintide (Symlin)FDA Link 01/2021
1	ertugliflozinIBA 01/2021
1	dulaglutideIBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019
1	SymportersIBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019

5	Therapeutics 10/2023 - 01/2019
2	Glycemic Control 05/2024 - 12/2023
2	Surgical Amputation (Amputations) 01/2020 - 01/2020
1	Drug Therapy (Chemotherapy) 05/2024